Basic Information
Basic information for NR2F1-AS1-223-11aa-3
Peptide Name NR2F1-AS1-223-11aa-3
Genome Position chr5:93537151-93537183[-]
Species Human
Peptide Sequence MSDCGPLYIHF
Peptide Length 11
Unique No (NR2F1-AS1-201-11aa,NR2F1-AS1-202-11aa-2,NR2F1-AS1-209-11aa-2,NR2F1-AS1-215-11aa,NR2F1-AS1-228-11aa,NR2F1-AS1-237-11aa,NR2F1-AS1-244-11aa-1,NR2F1-AS1-246-11aa-2,NR2F1-AS1-265-11aa-2,NR2F1-AS1-269-11aa-1,NR2F1-AS1-271-11aa-1)
Grand Average of Hydropathicity 0.4273
Relative Molecular Mass 1462.64
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000653643;NR2F1-AS1-223
Transcript Length 8117
Coding Ability 0.316
DNA Sequence Corresponding to Peptide ATGTCAGACTGTGGGCCTTTGTATATACACTTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :